MarketPeel
Insider Trading Intelligence
Pricing
…
JJ

John Johnson

AXGN
DIRECTOR · AXOGEN, INC. · CIK 0001410781
FILING MIX · LIFETIME74%/26%
BUYS
48
SELLS
17
TOTAL VALUE
$4.65M
COMPANIES
3
ACTIVE SINCE
Apr 2020
HOLDINGS NOW
764,334
AVG SELL PX
$11.83
TRADE KIND
SHOWING 65 / 65
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
8 backtested trades · 8 horizons · 18 pending
Forward-return performance of every backtestable P/S trade by John Johnson, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d8+75.00%-3.02%+0.03%-3.05%-3.18%—
14d8+25.00%+3.69%+0.36%+4.09%+6.16%—
30d8+12.50%+6.12%+1.51%+4.61%+6.14%—
60d8(1 pending)+14.29%+13.14%+1.95%+11.19%+12.42%—
90d8(1 pending)+71.43%+1.97%+1.16%+0.82%-3.71%—
180d8(1 pending)+28.57%+52.48%+9.12%+43.35%+31.14%—
1y8(7 pending)+0.00%+298.27%+23.27%+275.00%+275.00%—
2y8(8 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AXGN · 4,392 shares · as of Jun 24, 2026
07,25414,50821,76229,01620222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 48 buys / 17 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
4,392——4,392Jun 24, 2026Jun 26, 2026 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
14,150——14,150Jun 19, 2026Jun 23, 2026 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
14,150——0Jun 19, 2026Jun 23, 2026 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
15,000$6.09$91.4K683,083Jun 4, 2026Jun 5, 2026 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
32,996$6.15$202.9K32,996Jun 4, 2026Jun 5, 2026 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
24,193——707,276Jun 4, 2026Jun 5, 2026 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
36,000——52,666May 21, 2026May 26, 2026 ↗View →
AXGN
AXOGEN, INC.
SALE
11,050$43.26$478.0K0May 7, 2026May 8, 2026 ↗View →
AXGN
AXOGEN, INC.
SALE
11,050——0May 7, 2026May 8, 2026 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
11,050$7.04$77.8K11,050May 7, 2026May 8, 2026 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
135,400$7.22$977.0K698,083Dec 19, 2025Dec 19, 2025 ↗View →
AXGN
AXOGEN, INC.
SALE
8,545$29.98$256.2K13,141Dec 9, 2025Dec 10, 2025 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
8,545$6.30$53.8K21,686Dec 9, 2025Dec 10, 2025 ↗View →
AXGN
AXOGEN, INC.
SALE
8,545——0Dec 9, 2025Dec 10, 2025 ↗View →
AXGN
AXOGEN, INC.
SALE
13,141$29.98$394.0K0Dec 9, 2025Dec 10, 2025 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
11,891$6.30$74.9K25,032Dec 8, 2025Dec 10, 2025 ↗View →
AXGN
AXOGEN, INC.
SALE
11,891$31.22$371.3K13,141Dec 8, 2025Dec 10, 2025 ↗View →
AXGN
AXOGEN, INC.
SALE
11,802$31.26$368.9K13,141Dec 8, 2025Dec 10, 2025 ↗View →
AXGN
AXOGEN, INC.
SALE
11,891——8,545Dec 8, 2025Dec 10, 2025 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
107,500$7.32$786.5K833,483Aug 13, 2025Aug 15, 2025 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
14,150——14,150Jun 19, 2025Jun 20, 2025 ↗View →
AXGN
AXOGEN, INC.
SALE
4,073$10.61$43.2K24,943Jun 9, 2025Jun 11, 2025 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
50,000——940,983Jun 4, 2025Jun 4, 2025 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
8,333——16,666May 22, 2025May 27, 2025 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
12,500——12,500May 22, 2025May 27, 2025 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
11,904——29,016Sep 1, 2024Sep 4, 2024 ↗View →
AXGN
AXOGEN, INC.
SALE
11,904——0Sep 1, 2024Sep 4, 2024 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
8,333——8,333Jun 18, 2024Jun 20, 2024 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
12,500——12,500Jun 18, 2024Jun 20, 2024 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
10,653——17,112Jun 6, 2024Jun 10, 2024 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
18,248——18,248Jun 6, 2024Jun 10, 2024 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
50,000——890,983Jun 5, 2024Jun 5, 2024 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
SALE
215,600——0Mar 18, 2024Mar 18, 2024 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASE
215,600$1.99$429.0K751,412Mar 18, 2024Mar 18, 2024 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASE
89,571——840,983Mar 15, 2024Apr 1, 2024 ↗View →
VSTM
VERASTEM, INC.
SALE
2,083——0Mar 11, 2024Mar 13, 2024 ↗View →
VSTM
VERASTEM, INC.
SALE
2,300——0Mar 11, 2024Mar 13, 2024 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
8,549——8,549Mar 11, 2024Mar 13, 2024 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
20,436——20,436Sep 1, 2023Sep 6, 2023 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
11,904——11,904Sep 1, 2023Sep 6, 2023 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
42,500——535,812Jun 7, 2023Jun 7, 2023 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
6,459——6,459Jun 1, 2023Jun 5, 2023 ↗View →
AXGN
AXOGEN, INC.
SALE
6,459——0Jun 1, 2023Jun 5, 2023 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
62,500——62,500May 15, 2023May 16, 2023 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
62,500——62,500Jun 22, 2022Jun 24, 2022 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
15,000——493,312Jun 8, 2022Jun 9, 2022 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
25,000——25,000Jun 8, 2022Jun 9, 2022 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
6,459——6,459Jun 1, 2022Jun 3, 2022 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
11,811——11,811Jun 1, 2022Jun 3, 2022 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
62,500——62,500May 12, 2022Dec 20, 2022 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
31,360——31,360Oct 5, 2021Oct 5, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
10,367——10,367Oct 5, 2021Oct 8, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
478,312——478,312Oct 5, 2021Oct 8, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
68,600——68,600Oct 5, 2021Oct 8, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
31,360——31,360Oct 5, 2021Oct 8, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
215,600——215,600Oct 5, 2021Oct 8, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
68,600——68,600Oct 5, 2021Oct 5, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
215,600——215,600Oct 5, 2021Oct 5, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
10,367——10,367Oct 5, 2021Oct 5, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
478,312——478,312Oct 5, 2021Oct 5, 2021 ↗View →
XERS
XERIS BIOPHARMA HOLDINGS, INC.
PURCHASEGRANT
Stock grant
19,650$2.37$46.6K19,650Oct 5, 2021Oct 8, 2021 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
27,638——27,638Jul 19, 2021Jul 21, 2021 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
25,000——25,000Jun 28, 2021Jun 30, 2021 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
27,602——27,602Jun 16, 2020Jun 18, 2020 ↗View →
VSTM
VERASTEM, INC.
PURCHASEGRANT
Stock grant
25,000——25,000Apr 29, 2020Apr 29, 2020 ↗View →
Other insiders · AXGN
Loading peer insiders…
About this filer
CIK 0001410781
ROLE
Director
PRIMARY
AXGN
COMPANIES
3
ACTIVE SINCE
Apr 2020
MARKETPEEL · /INSIDER/0001410781DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback